Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Altered expression of breast cancer metastasis suppressor 1 (BRMS1), is a tumor suppressor, which is found in many types of cancers, including gastric cancer (GC), but the mechanism by which BRMS1 inhibits invasion and metastasis in GC is unknown.
|
31571904 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Human breast carcinoma metastasis‑suppressor 1 (BRMS1) is a tumor‑suppressor gene, that reduces the metastatic ability of tumor cells without affecting their tumorigenicity.
|
31233204 |
2019 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Low BRMS1 expression was associated with higher pathologic T stage (p = 0.001), larger tumor size (p ≤ 0.0001), greater lymphatic (p = 0.032) and vascular (p = 0.001) invasion, LUAD histologic subtype (p = 0.001), and intermediate and high architectural tumor grade (p = 0.003).
|
29097253 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We also found strong correlations between BRMS1 mRNA levels and TNM stage and tumor size.
|
29970691 |
2018 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In this study, death-associated protein kinase 1 (DAPK1), a tumor suppressor gene with multiple roles in regulating cell death, was identified as a potential transcriptional target of BRMS1 in the whole genome expression microarray.
|
28339067 |
2017 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We also found strong correlations between BRMS1 mRNA levels and TNM stage and tumor size.
|
28533425 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Breast cancer metastasis suppressor 1 (BRMS1) is a tumor suppressor gene, its expression being regulated by DNA promoter methylation in several types of cancers.
|
28381193 |
2017 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Breast cancer metastasis suppressor gene-1 (BRMS1) is newly discovered tumor metastasis gene, which has been reported to play an important role in the progression of human tumor.
|
24748145 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Using the tissue microarray technology, we found that BRMS1 expression is significantly decreased in glioma compared with tumor adjacent normal brain tissue (P<0.01, χ(2) test) and reduced BRMS1 staining is associated with WHO stages (P<0.05, χ(2) test).
|
24879377 |
2014 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Finally, significantly low levels of BRMS1 were observed in patients with high-grade tumors (p=0.12), in patients with distant metastasis (p=0.05) and those who died of breast cancer (p=0.0037).
|
24596389 |
2014 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
BRMS1 rs3116068 was associated with increased likelihood of having the luminal B and the HER2-enriched tumor subtype (P trend = 0.03).
|
23771732 |
2013 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Taken together, our results suggest a potential role for BRMS1.vh in regulating cell apoptosis and tumor growth in HCC.
|
23643861 |
2013 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
We analyzed associations between the methylation of BRMS1 genes separately and available epidemiologic and clinical information including smoking status, gender, age, and histological type, or the stage of the tumor.
|
21726917 |
2011 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, reduced BRMS1 staining was significantly correlated with American Joint Committee on Cancer stages (P=0.011, χ(2) test), but not associated with tumor thickness, tumor ulceration and other clinicopathological parameters.
|
20935672 |
2011 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Restoring BReast cancer Metastasis Suppressor 1 (BRMS1) expression suppresses metastasis in MDA-MB-435 human breast carcinoma cells at ectopic sites without affecting tumor formation at orthotopic site in the body.
|
20083343 |
2010 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Pathological tumour stage was associated with increased BRMS1 methylation in squamous cell cancers.
|
20455258 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Moreover, preservation of tumor BRMS1 expression is associated with improved patient survival.
|
19111386 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Since tumor protein expression analysis increasingly guides therapy decisions, our data may be of clinical benefit in disease management including profiling for BRMS1 expression before start of therapy.
|
19307053 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis of multiple tumor types without blocking tumorigenesis.
|
19585508 |
2009 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Analysis of microarray data provided insight into some of the potential mechanisms by which BRMS1 inhibits tumor formation at secondary sites.
|
17896182 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
One possible explanation is that epithelial cells increase their BRMS1 expression as a compensatory response to tumor formation or metastasis progression, which is elevated in proportion to tumor aggressiveness, whereas those cells of the primary tumor that cannot upregulate BRMS1 escape to form metastasis.
|
17163420 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The breast cancer metastasis suppressor 1 (BRMS1) gene has been shown to suppress metastasis without affecting the growth of the primary tumor in mouse models.
|
17854218 |
2007 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
It was found that BRMS1 mRNA was expressed at significantly higher levels in patients>50 years of age, with tumor size<2 cm, or with progesterone receptor-positive and HER2-negative tumors.
|
17085653 |
2006 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Thus, BRMS1 functions as a metastasis suppressor in more than one tumor type (i.e., breast carcinoma and cutaneous melanoma) by modifying several metastasis-associated phenotypes.
|
11822878 |
2002 |